X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
FDC LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

FDC LIMITED  (FDCL)


Here is the latest financial fact sheet of FDC LTD.. For more details, see the FDC LTD. quarterly results and FDC LTD. share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
fdc ltd. - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 199.1       No. of shares m 177.83
    Mkt Cap Rs m 35,397       % ch % -0.6
    Vol '000 3.9       % ch week % -2.8
    P/E X 20.1       % ch 1-mth % -1.8
    P/CF X 19.4       % ch 12-mth % 12.6
    EPS (TTM) Rs 9.9       52 week H/L Rs 240.0/165.5
(As on Apr 28, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs84118111106144 
Low Rs3179767579 
Sales per share (Unadj.) Rs33.938.638.842.747.6 
Earnings per share (Unadj.) Rs8.08.27.38.67.6 
Diluted earnings per shareRs8.48.57.58.77.6 
Cash flow per share (Unadj.) Rs8.99.18.310.19.0 
Dividends per share (Unadj.) Rs1.752.002.002.252.25 
Adj. dividends per shareRs1.832.082.062.292.25 
Dividend yield (eoy) %3.02.02.12.52.0 
Book value per share (Unadj.) Rs28.333.438.043.447.5 
Adj. book value per shareRs29.634.739.144.147.5 
Shares outstanding (eoy) m186.28184.57182.92180.83177.83 
Bonus/Rights/Conversions  BBBBBBBBBB 
Price / Sales ratio x1.72.62.42.12.3 
Avg P/E ratio x7.212.012.810.514.6 
P/CF ratio (eoy) x6.510.811.28.912.3 
Price / Book Value ratio x2.02.92.52.12.3 
Dividend payout %21.924.527.326.229.6 
Avg Mkt Cap Rs m10,71118,18017,10316,36519,784 
No. of employees `000NANANANANA 
Total wages/salary Rs m7248569901,0751,221 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
  INCOME DATA
Net Sales Rs m6,3217,1177,1057,7288,459 
Other income Rs m314283278463394 
Total revenues Rs m6,6367,3997,3838,1928,852 
Gross profit Rs m1,6621,6591,6431,8092,070 
Depreciation Rs m159174184279249 
Interest Rs m1114141631 
Profit before tax Rs m1,8061,7541,7221,9772,184 
Minority Interest Rs m00000 
Prior Period Items Rs m-23-1732-225 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m292228384427606 
Profit after tax Rs m1,4911,5091,3411,5521,353 
Gross profit margin %26.323.323.123.424.5 
Effective tax rate %16.213.022.321.627.7 
Net profit margin %23.621.218.920.116.0 
  BALANCE SHEET DATA
Current assets Rs m1,6464,4694,4404,0734,355 
Current liabilities Rs m1,2441,2351,3691,5041,792 
Net working cap to sales %6.445.443.233.230.3 
Current ratio x1.33.63.22.72.4 
Inventory Days Days5250534744 
Debtors Days Days2121222025 
Net fixed assets Rs m2,8562,8693,0382,9643,025 
Share capital Rs m187185184182179 
"Free" reserves Rs m4,9165,9676,7377,6288,243 
Net worth Rs m5,2666,1646,9547,8428,453 
Long term debt Rs m4625201511 
Total assets Rs m6,7957,6978,6289,66310,557 
Interest coverage x166.7122.8123.1124.671.4 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.90.80.80.8 
Return on assets %22.119.815.716.213.1 
Return on equity %28.324.519.319.816.0 
Return on capital %33.828.324.925.423.5 
Exports to sales %8.89.411.812.113.3 
Imports to sales %7.34.24.03.63.3 
Exports (fob) Rs m5596708419371,126 
Imports (cif) Rs m461296286279283 
Fx inflow Rs m5626728459591,146 
Fx outflow Rs m478315310347355 
Net fx Rs m83357534612791 
  CASH FLOW
From Operations Rs m 1,686 1,207 1,443 1,499 1,485 
From Investments Rs m -1,270 -330 -1,083 -1,072 -620 
From Financial Activity Rs m -373 -575 -582 -628 -753 
Net Cashflow Rs m 43 302 -221 -201 113 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for fdc limited

 Share Holding
Indian Promoters : 68.9%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 4.7%
FIIs : 7.5%
ADR/GDR : 0.0%
Free float : 19.0%
Shareholders : 23,730
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: B-8, MIDC Industrial Estate, Waluj Dist., Aurangabad - 431 136
    E-MAIL: investors@fdcindia.com     WEB: www.fdcindia.com
    TELEPHONE: (0240) 255 4407     FAX: (0240) 255 4299
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Sharex Dynamic, 1, Luthra Indl. Estate, Safed Pool, Andheri (E), Mumbai-72
    AUDITOR: S. R. Batliboi & Co.
CHM: M. A. Chandavarkar (MD) COMP SEC: Varsharani Katre YEAR OF INC: 1900 BSE CODE: 531599 FV (Rs): 1 DIV YIELD (%): 1.1

More pharmaceuticals Company Fact Sheets:   PANACEA BIOTECHMERCK LTDELDER PHARMASANOFI INDIAJ.B.CHEMICALS


Today's Market

Global Markets Ends the Week Higher on the Back of French Election Results(RoundUp)

Financial markets received a boost earlier in the week by news that centrist Emmanuel Macron had triumphed over far-right candidate Marine Le Pen in the first round of France's presidential election.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

We Don't Want More F&O Stocks... We Need Smaller Lot Sizes(Daily Profit Hunter)

Apr 26, 2017

Are you excited to trade in the sixteen new stocks to be introduced in the F&O segment this Friday?

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

In an Ocean of Corporate Defaulters, Vijay Mallya is a Small Fish(Vivek Kaul's Diary)

Apr 20, 2017

While it is important to get Mallya back to India, the government needs to show the same vigour in chasing defaulters of public sector bank loans residing in India.

4 Ways GST Will Impact The Mutual Fund Industry(Outside View)

Apr 19, 2017

PersonalFN explains how GST would impact India's mutual fund industry and investors

More

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FDC LTD.

FDC LTD. - TEVA PHARMA COMPARISON

Compare Company With Charts

COMPARE FDC LTD. WITH

MARKET STATS